CYTOMX THERAPEUTICS INC (CTMX)
US23284F1057 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 16.53M | -569.00K | -99.30M | -115.90M | -32.90M | |||
| Depreciation Amortization | 2.04M | 2.17M | 2.40M | 2.70M | 2.50M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -114.14M | -62.51M | -30.70M | -22.40M | 18.10M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | 4.09M | 4.87M | 16.70M | 16.60M | 17.40M | |||
| OPERATING CASH FLOW | -91.38M | -56.03M | -110.80M | -119.00M | 5.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -955.00K | -840.00K | -1.70M | -1.60M | -2.30M | |||
| Other Investing Activity | 41.77M | -149.83M | 100.00M | 24.10M | -16.40M | |||
| INVESTING CASH FLOW | 40.81M | -150.67M | 98.30M | 22.50M | -18.70M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 30.40M | 30.23M | N/A | 110.20M | 16.90M | |||
| Other Financing Activity | N/A | N/A | 600.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 30.40M | 30.23M | 600.00K | 110.20M | 16.90M | |||
| CHANGE IN CASH | -20.17M | -176.48M | -11.90M | 13.70M | 3.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -91.38M | -56.03M | -110.80M | -119.00M | 5.30M | |||
| Capital Expenditure | -955.00K | -840.00K | -1.70M | -1.60M | -2.30M | |||
| FREE CASH FLOW | -92.33M | -56.88M | -112.50M | -120.60M | 3.00M | |||
All data in USD